This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a firm fixed price ceiling value of $2,401.44 and a period of performance through March 17, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of ABRYSVO VIAL WITH DILUENT SYRGS medical supplies. The award has a ceiling value of $19,441.62 and an ultimate completion date of February 7, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a firm fixed price of $1,440.40 and a completion date of May 19, 2025. The contract is not a set-aside and was awarded on May 16, 2025. Amerisourcebergen Drug Corp is the prime contractor and has a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. The contract has a firm fixed price of $8,063.70 and a completion date of October 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of "ABRYSVO VIAL WITH DILUENTS" medical products. The contract has a total ceiling value of $8,657.20 and a completion date of July 17, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, with a ceiling value of $4,802.88 and a period of performance through April 30, 2025. The contract is a firm fixed-price delivery order, and it is not set-aside. Amerisourcebergen Drug Corp is the prime contractor, and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, with a potential value of $1,583.20 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, under a firm fixed-price contract with a ceiling value of $34,628.80. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a ceiling value of $8,004.80. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,684.99 firm-fixed-price contract is for the provision of ABRYSVO VIAL WITH DILUENTS, a medical product. The contract has an ultimate completion date of January 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...